Auflistung nach Autor "Vandoros, G. P."
Anzeige der Dokumente 1-3 von 3
-
Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy
Zachos, I.; Konstantinopoulos, P. A.; Vandoros, G. P.; Karamouzis, M. V.; Papatsoris, A. G.; Podimatas, T.; Papachristodoulou, A.; Chrisofos, M.; Deliveliotis, C.; Papavassiliou, A. G. (2009)We conducted a prospective study to determine whether expression of telomerase reverse transcriptase (hTERT) is associated with recurrence-free-survival (RFS) or development of invasive disease in patients with high risk ... -
Previous Bladder Cancer History in Patients with High-Risk, Non-muscle-invasive Bladder Cancer Correlates with Recurrence and Progression: Implications of Natural History
Mitrakas, L. P.; Zachos, I. V.; Tzortzis, V. P.; Gravas, S. A.; Rouka, E. C.; Dimitropoulos, K. I.; Vandoros, G. P.; Karatzas, A. D.; Melekos, M. D.; Papavassiliou, A. G. (2015)Purpose The purpose of this study was to assess the correlation of previous bladder cancer history with the recurrence and progression of patients with high-risk non-muscle-invasive bladder cancer treated with adjuvant ... -
Tumor size and T stage correlate independently with recurrence and progression in high-risk non-muscle-invasive bladder cancer patients treated with adjuvant BCG
Zachos, I.; Tzortzis, V.; Mitrakas, L.; Samarinas, M.; Karatzas, A.; Gravas, S.; Vandoros, G. P.; Melekos, M. D.; Papavassiliou, A. G. (2014)We conducted a retrospective study to determine the prognostic significance of age, gender, associated carcinoma in situ, stage, number of tumors, and tumor size for patients with high-risk non-muscle-invasive bladder ...